Doherty V R, MacKie R M
Br Med J (Clin Res Ed). 1986 Apr 12;292(6526):987-9. doi: 10.1136/bmj.292.6526.987.
One hundred and twenty five patients presenting in the west of Scotland with primary cutaneous malignant melanoma answered a detailed questionnaire to establish whether there was any evidence of inappropriate delay in receiving surgical treatment for a new or changing pigmented lesion. The survey was carried out because of the relatively high proportion of patients in Scotland with melanoma presenting with primary lesions categorised as "thick, poor prognosis" and the poor five year survival figures as compared with many other countries. Of the 125 patients questioned, only 20 (16%) had received appropriate surgical treatment within three months of becoming aware of a suspicious cutaneous pigmented lesion; 63 (50%) had received surgical treatment three to 12 months after first noticing such a change, and in 42 cases (34%) this interval was over one year. In 102 of 105 patients in whom the interval exceeded three months the patient alone was responsible for the delay; in only three cases was the family doctor partially at fault. No evidence of delay by the hospital service was identified. Because of these findings a public education campaign was launched in the west of Scotland in June 1985 with the aim of improving recognition of early malignant melanoma. In the next six months the proportion of patients in the west of Scotland with primary melanomas categorised as "thin, good prognosis" had risen from 38% to 62%, and the proportion with tumours categorised as "thick, poor prognosis" had fallen from 34% to 15%.
125名在苏格兰西部被诊断为原发性皮肤恶性黑色素瘤的患者填写了一份详细问卷,以确定对于新出现或有变化的色素沉着病变,是否存在接受手术治疗延迟不当的证据。开展这项调查的原因是,在苏格兰,与许多其他国家相比,被诊断为原发性“厚、预后差”病变的黑色素瘤患者比例相对较高,且五年生存率较低。在接受询问的125名患者中,只有20名(16%)在意识到皮肤色素沉着病变可疑后的三个月内接受了适当的手术治疗;63名(50%)在首次注意到这种变化后的三至十二个月接受了手术治疗,42例(34%)的这一间隔超过一年。在间隔超过三个月的105名患者中,有102名患者的延迟是由其自身造成的;只有三例家庭医生负有部分责任。未发现医院服务存在延迟的证据。基于这些发现,1985年6月在苏格兰西部发起了一场公众教育运动,目的是提高对早期恶性黑色素瘤的认识。在接下来的六个月里,苏格兰西部被诊断为原发性黑色素瘤且分类为“薄、预后好”的患者比例从38%上升到了62%,而分类为“厚、预后差”的肿瘤患者比例则从34%下降到了15%。